Cover Image
Market Research Report

U.S. Contract Research Organization Market, by Service Type, by Therapeutic Application, and by Size of CRO - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published by Coherent Market Insights Product code 920684
Published Content info 301 Pages
Delivery time: 2-3 business days
Price
Back to Top
U.S. Contract Research Organization Market, by Service Type, by Therapeutic Application, and by Size of CRO - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Published: December 23, 2019 Content info: 301 Pages
Description

Title:
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I - IIa, Phase IIa - III, Phase IIIb - IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small Size, Medium Size, and Large Size) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

A contract research organization (CRO) offers effective services to pharmaceutical and biotechnology organizations by reducing cost and time period required to conduct the clinical trial. The U.S. continues to be the one of the largest market for pharmaceutical research and development, thereby providing growth opportunities for contract research organizations (CROs). CROs offer drug discovery services such as drug target identification, drug discovery screening, library screening, fragment-based drug design, ligand-based drug design, ligand protein binding, drug profiling, lead identification, lead compound identification, and lead optimization. CROs conducts clinical trial studies (from phase I to phase IV). It is also engaged in medical coding, monitoring, clinical data management, protocol development, and other services which are included in clinical development of any drug molecules.

Market Dynamics:

Rising number of U.S. Food and Drug Administration (FDA) approvals and clinical trials are supporting growth of biopharmaceutical industry are expected to fuel growth of the U.S. contract research organization (CROs) market. The U.S. is expected to hold dominant position in the contract research organization market over the forecast period due to rising demand for generic drugs, increasing clinical research and development activities, and government support. The U.S. is one of the biggest market for contract research organization due increasing pharmaceutical research and development activities in the country, thereby providing growth opportunities for contract research organizations (CROs). For instance, according to the clinicaltrials.gov, from September 2008 to October 2019, around 34% (125,000) of clinical trial studies were performed in the U.S. out of 317,865 studies, globally.

Key features of the study::

  • This report provides in-depth analysis of the U.S. contract research organization (CROs) market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2019-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline drugs, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global U.S. contract research organization (CROs) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Key companies covered as a part of this study include Laboratory Corporation of America Holdings (Covance), IQVIA, Paraxel International Corporation, Syneos Health, PRA Health Sciences, Charles River Laboratoires International Inc. (CRL), Pharmaceutical Product Development (PPD), ICON Public Limited Corporation, Wuxi Apptec,Medpace Holdings, Inc,Medidata Solutions, Inc., Theorem Clinical Research, Pharmaron, Envigo, Clinipace, CMIC Holdings Co., Ltd, EPS International, Synteract, CROMSOURCE, Pharm-Olam, Linical Accelovance, Accumedix, Inc., AlcheraBio LLC, Amarex Clinical Research LLC, Arianne Corporation, Absolute Research Solutions, BioClinica Inc., BioPharma Services Inc., Neurovasc Preclinical Services, Inc., PSI, WCCT Global Inc., RHO, Inc., CATO Research LLC, Spaulding Clinical Research, Celerion, Clindatrix, Inc., Comparative Biosciences, Inc., Axiom Real-Time Metrics, CPC Clinical Research, Axis Clinicals LLC, DP Clinical, Egeen Inc., Grayline, Cmed, Integrium, LLC, MedTrials, Novum, Shin Nippon Biomedical Laboratories, Ltd., KPS Life, Pinnacle Research Group, LLC Promedica International., Alta Science, Prometrika, LLC, 4clinics, and Premier Research.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launches, market expansion, and marketing tactics
  • The global U.S. contract research organization (CROs) market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, CROs, medical device companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the U.S. contract research organization (CROs) market

Detailed Segmentation::

  • U.S. Contract Research Organization (CROs) Market, By Service Type:
    • Drug Discovery
    • Preclinical studies
    • Early Phase I - Iia
    • Phase Iia - III
    • Phase IIIb - IV
    • Drug Development
    • Medical Coding and Writing
    • Monitoring
    • Clinical Data Management
    • Bio-statistics
    • Site Management
    • Protocol Development
    • Biomarker Discovery
  • U.S. Contract Research Organization (CROs) Market, By Therapeutic Application:
    • Oncology
    • Cardiovascular Diseases
    • Central Nervous System Diseases
    • Infectious Diseases
    • Metabolic Disorders
    • Immunological Disorders
    • Respiratory Disorders
    • Others
  • U.S. Contract Research Organization (CROs) Market, By Size of CRO:
    • Small Size
    • Medium Size
    • Large Size
  • Company Profiles
    • Laboratory Corporation of America Holdings (Covance) *
      • Company Overview
      • Product Portfolio
      • Market Presence
      • Financial Overview
      • Key Developments
      • Strategies
    • IQVIA
    • Paraxel International Corporation
    • Syneos Health
    • PRA Health Sciences
    • Charles River Laboratoires International Inc. (CRL)
    • Pharmaceutical Product Development (PPD)
    • ICON Public Limited Corporation
    • Wuxi Apptec
    • Medpace Holdings, Inc
    • Medidata Solutions, Inc.
    • Theorem Clinical Research
    • Pharmaron
    • Envigo
    • Clinipace
    • CMIC Holdings Co., Ltd
    • EPS International
    • Synteract
    • CROMSOURCE
    • Pharm-Olam
    • Linical Accelovance
    • Accumedix, Inc.
    • AlcheraBio LLC
    • Amarex Clinical Research LLC
    • Arianne Corporation
    • Absolute Research Solutions
    • BioClinica Inc.
    • BioPharma Services Inc.
    • Neurovasc Preclinical Services, Inc.
    • PSI
    • WCCT Global Inc
    • RHO, Inc.
    • CATO Research LLC
    • Spaulding Clinical Research
    • Celerion
    • Clindatrix, Inc.
    • Comparative Biosciences, Inc.
    • Axiom Real-Time Metrics
    • CPC Clinical Research
    • Axis Clinicals LLC
    • DP Clinical
    • Egeen Inc.
    • Grayline
    • Cmed
    • Integrium, LLC
    • MedTrials
    • Novum
    • Shin Nippon Biomedical Laboratories, Ltd.
    • KPS Life
    • Pinnacle Research Group, LLC
    • Promedica International.
    • Alta Science
    • Prometrika, LLC
    • 4clinics
    • Premier Research

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Service Type
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By Size of CRO
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints & Challenges
    • Market Opportunities
    • Merger and Acquisitions
    • Key to a Successful CTMS Solution

4. U.S. Contract Research Organization (CROs) Market, By Service Type, 2016 - 2027 (US$ Million)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2016 - 2027
    • Segment Trends
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Preclinical studies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Early Phase I - Iia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Phase IIa - III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Phase IIIb - IV
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Drug Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Medical Coding and Writing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Monitoring
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Clinical Data Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Bio-statistics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Site Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Protocol Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Biomarker Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

5. U.S. Contract Research Organization (CROs) Market, By Therapeutic Application, 2016 - 2027 (US$ Million)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2016 - 2027
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Central Nervous System Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Immunological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Respiratory Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. U.S. Contract Research Organization (CROs) Market, By Size of CRO, 2016 - 2027 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2016 - 2027
    • Segment Trends
  • Small Size
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Medium Size
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Large Size
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Laboratory Corporation of America Holdings (Covance) *
    • Company Overview
    • Product Portfolio
    • Market Presence
    • Financial Overview
    • Key Developments
    • Strategies
    • IQVIA
    • Paraxel International Corporation
    • Syneos Health
    • PRA Health Sciences
    • Charles River Laboratoires International Inc. (CRL)
    • Pharmaceutical Product Development (PPD)
    • ICON Public Limited Corporation
    • Wuxi Apptec
    • Medpace Holdings, Inc
    • Medidata Solutions, Inc.
    • Theorem Clinical Research
    • Pharmaron
    • Envigo
    • Clinipace
    • CMIC Holdings Co., Ltd
    • EPS International
    • Synteract
    • CROMSOURCE
    • Pharm-Olam
    • Linical Accelovance
    • Accumedix, Inc.
    • AlcheraBio LLC
    • Amarex Clinical Research LLC
    • Arianne Corporation
    • Absolute Research Solutions
    • BioClinica Inc.
    • BioPharma Services Inc.
    • Neurovasc Preclinical Services, Inc.
    • PSI
    • WCCT Global Inc
    • RHO, Inc.
    • CATO Research LLC
    • Spaulding Clinical Research
    • Celerion
    • Clindatrix, Inc.
    • Comparative Biosciences, Inc.
    • Axiom Real-Time Metrics
    • CPC Clinical Research
    • Axis Clinicals LLC
    • DP Clinical
    • Egeen Inc.
    • Grayline
    • Cmed
    • Integrium, LLC
    • MedTrials
    • Novum
    • Shin Nippon Biomedical Laboratories, Ltd.
    • KPS Life
    • Pinnacle Research Group, LLC
    • Promedica International.
    • Alta Science
    • Prometrika, LLC
    • 4clinics
    • Premier Research
  • Analyst Views

8. Section

  • Research Methodology
  • About us and Services

"*" marked represents similar segmentation in other categories in the respective section.

Back to Top